[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation].

[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation]. Bull Cancer. 2020 Sep 14;: Authors: Hilmi M, Neuzillet C PMID: 32943226 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32943226?dopt=Abstract

Source: Bulletin du Cancer - September 13, 2020 Category: Cancer & Oncology Authors: Hilmi M, Neuzillet C Tags: Bull Cancer Source Type: research

More News: Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Science